SlideShare une entreprise Scribd logo
1  sur  24
Télécharger pour lire hors ligne
SWATI SARIN
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
PHASES OF DRUG DEVELOPMENT (ANIMAL  MAN) PHASE III PHASE IV PHASE I PHASE I PRECLINICAL PHASE II Product Approval (NDA/MAA) Patient studies Entry to man (IND / CTA) None Healthy   subjects Safety and tolerability Genetic   toxicity (in vivo) Repeat dose  toxicity  testing + Bioanalysis / Toxicokinetics Drug Metabolism Reproductive  Toxicity Testing (teratogenicity) Patients Small scale  efficacy studies Patients Large scale multicentre studies Chronic (long term) toxicity  testing + Bioanalysis / Toxicokinetics Reproductive Toxicity Testing  (fertility and pre/post natal) Carcinogenicity studies Drug Metabolism  Patients Large scale post-marketing  studies As required Genetic   toxicity (in vitro) Single / repeat dose  toxicity studies + Bioanalysis /    Toxicokinetics Safety Pharmacology Drug Metabolism Lead candidate Identified Clinical Non-clinical MOLECULE
[object Object],[object Object],[object Object],[object Object],[object Object]
TOXICOKINETIC STUDIES ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],b) REPEATED DOSE STUDIES/SUB-ACUTE OR CHRONIC TOXICITY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Fertility and general reproductive performance study Segment II Teratogenicity  Segment III Peri and post-natal study  Fertility and early embryonic development (rat)  Embryo- foetal development  (rat & rabbit) Post natal development (rat) (post natal survival of offspring), growth parameters, vital senses, behavioral effects ,[object Object],[object Object],Implantation  Embryogenesis
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],CONDUCT OF STUDY
EVALUATION OF RESULT  ,[object Object],[object Object],[object Object],[object Object],[object Object]
 

Contenu connexe

Tendances

Preclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilancePreclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilancekamrudeen samani
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dosepp_shivgunde
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesHimikaRathi
 
Oecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesOecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesJasdeep singh brar
 
Anesthetic agents used in laboratory animals
Anesthetic agents used in laboratory animalsAnesthetic agents used in laboratory animals
Anesthetic agents used in laboratory animalsDrSahilKumar
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
Introduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsIntroduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsKanthlal SK
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on ToxicokineticsDeepak Kumar
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Dr Ajay Mandal
 
Basic definition and types of toxicology
Basic definition and types of toxicologyBasic definition and types of toxicology
Basic definition and types of toxicologyAbhishekJoshi312
 

Tendances (20)

Preclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilancePreclinical studies, clinical trails and pharmacovigilance
Preclinical studies, clinical trails and pharmacovigilance
 
Schedule y
Schedule  ySchedule  y
Schedule y
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
 
Toxic studies
Toxic studiesToxic studies
Toxic studies
 
Phases of clinical trials
Phases of clinical trialsPhases of clinical trials
Phases of clinical trials
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
Toxicity studies
Toxicity studiesToxicity studies
Toxicity studies
 
Oecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesOecd guidelines for toxicology studies
Oecd guidelines for toxicology studies
 
Anesthetic agents used in laboratory animals
Anesthetic agents used in laboratory animalsAnesthetic agents used in laboratory animals
Anesthetic agents used in laboratory animals
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Introduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsIntroduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugs
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on Toxicokinetics
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
 
Toxikokinetics
ToxikokineticsToxikokinetics
Toxikokinetics
 
Basic definition and types of toxicology
Basic definition and types of toxicologyBasic definition and types of toxicology
Basic definition and types of toxicology
 
Chronotherapy
ChronotherapyChronotherapy
Chronotherapy
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
 
Experimental pharmacology
Experimental pharmacologyExperimental pharmacology
Experimental pharmacology
 

Similaire à Animal toxicology studies

animal toxicity studies
animal toxicity studiesanimal toxicity studies
animal toxicity studiesVishnu Vardhan
 
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYRahul Kadam
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptKarabiAdak
 
Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019Akanksha William
 
Toxicological approach for drug discovery
Toxicological approach for drug discovery Toxicological approach for drug discovery
Toxicological approach for drug discovery Dr Duggirala Mahendra
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdfChijiokeNsofor
 
Toxicological studies and bioequivalence
Toxicological studies and bioequivalenceToxicological studies and bioequivalence
Toxicological studies and bioequivalencevishnugm
 
SUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptxSUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptxssuser76945d
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studiesAzeemsales
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studiesAzeemsales
 
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdfgeneral-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdfJISUniversity3
 
Introduction to toxicology
Introduction to toxicologyIntroduction to toxicology
Introduction to toxicologyManojKumar109262
 
Drug development process
Drug development processDrug development process
Drug development processnasim arshadi
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoverySuhas Reddy C
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacologyLikith `HV
 
Preclinical & clinical sk
Preclinical & clinical skPreclinical & clinical sk
Preclinical & clinical skSumit Pal
 

Similaire à Animal toxicology studies (20)

animal toxicity studies
animal toxicity studiesanimal toxicity studies
animal toxicity studies
 
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
 
Pravin fianl
Pravin fianlPravin fianl
Pravin fianl
 
Experimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.pptExperimental Techniques For Evaluation Of New Drugs.ppt
Experimental Techniques For Evaluation Of New Drugs.ppt
 
Animal toxicity studies
Animal toxicity studiesAnimal toxicity studies
Animal toxicity studies
 
Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019Animal toxicity study requirements for conduct of clinical trial april 13 2019
Animal toxicity study requirements for conduct of clinical trial april 13 2019
 
Toxicological approach for drug discovery
Toxicological approach for drug discovery Toxicological approach for drug discovery
Toxicological approach for drug discovery
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdf
 
Toxicity studies
Toxicity studiesToxicity studies
Toxicity studies
 
Toxicological studies and bioequivalence
Toxicological studies and bioequivalenceToxicological studies and bioequivalence
Toxicological studies and bioequivalence
 
SUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptxSUBHAJIT_OECD422.pptx
SUBHAJIT_OECD422.pptx
 
Animal toxicity studies
Animal toxicity studiesAnimal toxicity studies
Animal toxicity studies
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdfgeneral-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
general-toxicity-study-designs-jan-willem-van-der-laan_en.pdf
 
Introduction to toxicology
Introduction to toxicologyIntroduction to toxicology
Introduction to toxicology
 
Drug development process
Drug development processDrug development process
Drug development process
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug Discovery
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacology
 
Preclinical & clinical sk
Preclinical & clinical skPreclinical & clinical sk
Preclinical & clinical sk
 

Plus de swati2084

Who expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsWho expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsswati2084
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitmentswati2084
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trialswati2084
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitmentswati2084
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Food drug and cosmetic act 1938
Food drug and cosmetic act 1938Food drug and cosmetic act 1938
Food drug and cosmetic act 1938swati2084
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drugswati2084
 
HIV and TB coinfection
HIV and TB coinfectionHIV and TB coinfection
HIV and TB coinfectionswati2084
 

Plus de swati2084 (8)

Who expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsWho expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical products
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitment
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trial
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitment
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Food drug and cosmetic act 1938
Food drug and cosmetic act 1938Food drug and cosmetic act 1938
Food drug and cosmetic act 1938
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
 
HIV and TB coinfection
HIV and TB coinfectionHIV and TB coinfection
HIV and TB coinfection
 

Dernier

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 

Dernier (20)

Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 

Animal toxicology studies

  • 2.
  • 3.
  • 4. PHASES OF DRUG DEVELOPMENT (ANIMAL MAN) PHASE III PHASE IV PHASE I PHASE I PRECLINICAL PHASE II Product Approval (NDA/MAA) Patient studies Entry to man (IND / CTA) None Healthy subjects Safety and tolerability Genetic toxicity (in vivo) Repeat dose toxicity testing + Bioanalysis / Toxicokinetics Drug Metabolism Reproductive Toxicity Testing (teratogenicity) Patients Small scale efficacy studies Patients Large scale multicentre studies Chronic (long term) toxicity testing + Bioanalysis / Toxicokinetics Reproductive Toxicity Testing (fertility and pre/post natal) Carcinogenicity studies Drug Metabolism Patients Large scale post-marketing studies As required Genetic toxicity (in vitro) Single / repeat dose toxicity studies + Bioanalysis / Toxicokinetics Safety Pharmacology Drug Metabolism Lead candidate Identified Clinical Non-clinical MOLECULE
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.